MinKyu Park

10PUBLICATIONS
36CO-AUTHORS
PharmacogenomicsGene and molecular therapyInstrumental methods (excl. immunological and bioassay methods)Molecular medicineToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 13, 2025
Impact of Renal Impairment on the Pharmacodynamic and Pharmacokinetic Profiles of Epaminurad, a Novel Uric Acid Transporter 1 Inhibitor.

Seo Yeong Park, Jun Gi Hwang, Sung Kweon Cho

|Mar 31, 2025
A First-In-Human Phase 1 Study to Evaluate the Safety and Tolerability of LEM-S401, a Novel siRNA-DegradaBALL Drug Targeting CTGF in Healthy Adults.

Ha-Yeon Kim, Jaeso Cho, Min Kyu Park

|Oct 10, 2024
Determination of a robust headspace GC-MS/MS method for analysis of ethyl alcohol and acetaldehyde: clinical application to pharmacokinetics study.

Hyun-A Oh, Min Kyu Park

|Oct 10, 2024
Advanced clinical symptoms of the antihangover compound HK-GCM-H01 in healthy Koreans.

Ye Lim Jang, Min Kyu Park

|Jun 21, 2024
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study.

Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin

|Apr 15, 2024
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes.

Sae Im Jeong, Mu Seong Ban, Jun-Gi Hwang

Pageof 2

Frequent Collaborators

7 joint publications

JunGi Hwang

3 joint publications

Sae Im Jeong

2 joint publications

Yu Kyong Kim

1 joint publications

Sook Joung Lee